Pharmacokinetics of Denopamine in Hemodialysis Patients
The pharmacokinetics of denopamine on a hemodialysis day and on an interdialysis day was evaluated in 11 hemodialysis patients. Tmax was the only pharmacokinetical parameter that differed significantly between healthy volunteers and hemodialysis patients. It is suggested that denopamine can be admin...
Gespeichert in:
| Veröffentlicht in: | Renal failure 1991, Vol.13 (1), p.37-41 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 41 |
|---|---|
| container_issue | 1 |
| container_start_page | 37 |
| container_title | Renal failure |
| container_volume | 13 |
| creator | Nakahama, Hajime Izumi, Masaaki Tanaka, Yoshimu Wada, Akira Fujita, Yoshimasa Orita, Yoshimasa Shirai, Dairoku Kamada, Takenobu |
| description | The pharmacokinetics of denopamine on a hemodialysis day and on an interdialysis day was evaluated in 11 hemodialysis patients. Tmax was the only pharmacokinetical parameter that differed significantly between healthy volunteers and hemodialysis patients. It is suggested that denopamine can be administered to hemodialysis patients both on hemodialysis days and on interdialysis days without dosage adjustments. |
| doi_str_mv | 10.3109/08860229109022145 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_1681572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72154747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-80ca8b88c6ca4f4518d9e50363bfd3e54be05b9f47b04c9834840d9287a6f56a3</originalsourceid><addsrcrecordid>eNp9kE9LwzAYh4Moc04_gAehB_FWTdqkSdGLzD8TBu6g4K28TROW2TYzaZF9ezM2FRF2ekN-z-8leRA6JfgyJTi_wkJkOEnycA6DULaHhoQlLM4wzffRcJ3HIXk7REfeLzAmTPBkgAYkE4TxZIj4bA6uAWnfTas6I31kdXSnWruEJtxEpo0mqrGVgXrljY9m0BnVdv4YHWiovTrZzhF6fbh_GU_i6fPj0_h2Gkua4i4WWIIohZCZBKopI6LKFcNplpa6ShWjpcKszDXlJaYyFykVFFd5IjhkmmWQjtDFZu_S2Y9e-a5ojJeqrqFVtvcFTwijnPIAkg0onfXeKV0snWnArQqCi7Ws4p-s0DnbLu_LRlW_jY2dkJ9vc_ASau2glcb_YAwnNOckYDcbzLTaBpmf1tVV0cGqtu67k-56xfWf-lxB3c0lOFUsbO_aoHfHH74AAbaVdw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72154747</pqid></control><display><type>article</type><title>Pharmacokinetics of Denopamine in Hemodialysis Patients</title><source>Taylor & Francis</source><source>MEDLINE</source><creator>Nakahama, Hajime ; Izumi, Masaaki ; Tanaka, Yoshimu ; Wada, Akira ; Fujita, Yoshimasa ; Orita, Yoshimasa ; Shirai, Dairoku ; Kamada, Takenobu</creator><creatorcontrib>Nakahama, Hajime ; Izumi, Masaaki ; Tanaka, Yoshimu ; Wada, Akira ; Fujita, Yoshimasa ; Orita, Yoshimasa ; Shirai, Dairoku ; Kamada, Takenobu</creatorcontrib><description>The pharmacokinetics of denopamine on a hemodialysis day and on an interdialysis day was evaluated in 11 hemodialysis patients. Tmax was the only pharmacokinetical parameter that differed significantly between healthy volunteers and hemodialysis patients. It is suggested that denopamine can be administered to hemodialysis patients both on hemodialysis days and on interdialysis days without dosage adjustments.</description><identifier>ISSN: 0886-022X</identifier><identifier>EISSN: 1525-6049</identifier><identifier>DOI: 10.3109/08860229109022145</identifier><identifier>PMID: 1681572</identifier><identifier>CODEN: REFAE8</identifier><language>eng</language><publisher>Colchester: Informa UK Ltd</publisher><subject>Adrenergic beta-Agonists - pharmacokinetics ; Adult ; Biological and medical sciences ; Cardiotonic agents ; Cardiovascular system ; Denopamine ; Ethanolamines - pharmacokinetics ; Hemodialysis ; Humans ; Hypotension - etiology ; Male ; Medical sciences ; Pharmacokinetics ; Pharmacology. Drug treatments ; Regression Analysis ; Renal Dialysis - adverse effects</subject><ispartof>Renal failure, 1991, Vol.13 (1), p.37-41</ispartof><rights>1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1991</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-80ca8b88c6ca4f4518d9e50363bfd3e54be05b9f47b04c9834840d9287a6f56a3</citedby><cites>FETCH-LOGICAL-c430t-80ca8b88c6ca4f4518d9e50363bfd3e54be05b9f47b04c9834840d9287a6f56a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.3109/08860229109022145$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.3109/08860229109022145$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,776,780,4010,27900,27901,27902,59620,60409,61194,61375</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=5024971$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1681572$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakahama, Hajime</creatorcontrib><creatorcontrib>Izumi, Masaaki</creatorcontrib><creatorcontrib>Tanaka, Yoshimu</creatorcontrib><creatorcontrib>Wada, Akira</creatorcontrib><creatorcontrib>Fujita, Yoshimasa</creatorcontrib><creatorcontrib>Orita, Yoshimasa</creatorcontrib><creatorcontrib>Shirai, Dairoku</creatorcontrib><creatorcontrib>Kamada, Takenobu</creatorcontrib><title>Pharmacokinetics of Denopamine in Hemodialysis Patients</title><title>Renal failure</title><addtitle>Ren Fail</addtitle><description>The pharmacokinetics of denopamine on a hemodialysis day and on an interdialysis day was evaluated in 11 hemodialysis patients. Tmax was the only pharmacokinetical parameter that differed significantly between healthy volunteers and hemodialysis patients. It is suggested that denopamine can be administered to hemodialysis patients both on hemodialysis days and on interdialysis days without dosage adjustments.</description><subject>Adrenergic beta-Agonists - pharmacokinetics</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cardiotonic agents</subject><subject>Cardiovascular system</subject><subject>Denopamine</subject><subject>Ethanolamines - pharmacokinetics</subject><subject>Hemodialysis</subject><subject>Humans</subject><subject>Hypotension - etiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Pharmacokinetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Regression Analysis</subject><subject>Renal Dialysis - adverse effects</subject><issn>0886-022X</issn><issn>1525-6049</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9LwzAYh4Moc04_gAehB_FWTdqkSdGLzD8TBu6g4K28TROW2TYzaZF9ezM2FRF2ekN-z-8leRA6JfgyJTi_wkJkOEnycA6DULaHhoQlLM4wzffRcJ3HIXk7REfeLzAmTPBkgAYkE4TxZIj4bA6uAWnfTas6I31kdXSnWruEJtxEpo0mqrGVgXrljY9m0BnVdv4YHWiovTrZzhF6fbh_GU_i6fPj0_h2Gkua4i4WWIIohZCZBKopI6LKFcNplpa6ShWjpcKszDXlJaYyFykVFFd5IjhkmmWQjtDFZu_S2Y9e-a5ojJeqrqFVtvcFTwijnPIAkg0onfXeKV0snWnArQqCi7Ws4p-s0DnbLu_LRlW_jY2dkJ9vc_ASau2glcb_YAwnNOckYDcbzLTaBpmf1tVV0cGqtu67k-56xfWf-lxB3c0lOFUsbO_aoHfHH74AAbaVdw</recordid><startdate>1991</startdate><enddate>1991</enddate><creator>Nakahama, Hajime</creator><creator>Izumi, Masaaki</creator><creator>Tanaka, Yoshimu</creator><creator>Wada, Akira</creator><creator>Fujita, Yoshimasa</creator><creator>Orita, Yoshimasa</creator><creator>Shirai, Dairoku</creator><creator>Kamada, Takenobu</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>1991</creationdate><title>Pharmacokinetics of Denopamine in Hemodialysis Patients</title><author>Nakahama, Hajime ; Izumi, Masaaki ; Tanaka, Yoshimu ; Wada, Akira ; Fujita, Yoshimasa ; Orita, Yoshimasa ; Shirai, Dairoku ; Kamada, Takenobu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-80ca8b88c6ca4f4518d9e50363bfd3e54be05b9f47b04c9834840d9287a6f56a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Adrenergic beta-Agonists - pharmacokinetics</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cardiotonic agents</topic><topic>Cardiovascular system</topic><topic>Denopamine</topic><topic>Ethanolamines - pharmacokinetics</topic><topic>Hemodialysis</topic><topic>Humans</topic><topic>Hypotension - etiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Pharmacokinetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Regression Analysis</topic><topic>Renal Dialysis - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakahama, Hajime</creatorcontrib><creatorcontrib>Izumi, Masaaki</creatorcontrib><creatorcontrib>Tanaka, Yoshimu</creatorcontrib><creatorcontrib>Wada, Akira</creatorcontrib><creatorcontrib>Fujita, Yoshimasa</creatorcontrib><creatorcontrib>Orita, Yoshimasa</creatorcontrib><creatorcontrib>Shirai, Dairoku</creatorcontrib><creatorcontrib>Kamada, Takenobu</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Renal failure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakahama, Hajime</au><au>Izumi, Masaaki</au><au>Tanaka, Yoshimu</au><au>Wada, Akira</au><au>Fujita, Yoshimasa</au><au>Orita, Yoshimasa</au><au>Shirai, Dairoku</au><au>Kamada, Takenobu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics of Denopamine in Hemodialysis Patients</atitle><jtitle>Renal failure</jtitle><addtitle>Ren Fail</addtitle><date>1991</date><risdate>1991</risdate><volume>13</volume><issue>1</issue><spage>37</spage><epage>41</epage><pages>37-41</pages><issn>0886-022X</issn><eissn>1525-6049</eissn><coden>REFAE8</coden><abstract>The pharmacokinetics of denopamine on a hemodialysis day and on an interdialysis day was evaluated in 11 hemodialysis patients. Tmax was the only pharmacokinetical parameter that differed significantly between healthy volunteers and hemodialysis patients. It is suggested that denopamine can be administered to hemodialysis patients both on hemodialysis days and on interdialysis days without dosage adjustments.</abstract><cop>Colchester</cop><pub>Informa UK Ltd</pub><pmid>1681572</pmid><doi>10.3109/08860229109022145</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0886-022X |
| ispartof | Renal failure, 1991, Vol.13 (1), p.37-41 |
| issn | 0886-022X 1525-6049 |
| language | eng |
| recordid | cdi_pubmed_primary_1681572 |
| source | Taylor & Francis; MEDLINE |
| subjects | Adrenergic beta-Agonists - pharmacokinetics Adult Biological and medical sciences Cardiotonic agents Cardiovascular system Denopamine Ethanolamines - pharmacokinetics Hemodialysis Humans Hypotension - etiology Male Medical sciences Pharmacokinetics Pharmacology. Drug treatments Regression Analysis Renal Dialysis - adverse effects |
| title | Pharmacokinetics of Denopamine in Hemodialysis Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T08%3A43%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20of%20Denopamine%20in%20Hemodialysis%20Patients&rft.jtitle=Renal%20failure&rft.au=Nakahama,%20Hajime&rft.date=1991&rft.volume=13&rft.issue=1&rft.spage=37&rft.epage=41&rft.pages=37-41&rft.issn=0886-022X&rft.eissn=1525-6049&rft.coden=REFAE8&rft_id=info:doi/10.3109/08860229109022145&rft_dat=%3Cproquest_pubme%3E72154747%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72154747&rft_id=info:pmid/1681572&rfr_iscdi=true |